Model Number 4712 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Nausea (1970); Pain (1994); Pneumothorax (2012)
|
Event Date 08/30/2022 |
Event Type
Injury
|
Event Description
|
It was reported that at the implant of an subcutaneous implantable cardioverter defibrillator (s-icd), defibrillation threshold (dft) testing was initially unsuccessful at 65 joules.Additional external and device shocks were delivered which were unsuccessful.A commanded 80 joule shock was delivered which successfully converted the patient.At the time of the unsuccessful dft it was suspected to be due to low ejection fraction, however in the recovery room the patient reported feeling severe pain and nausea.A chest x-ray was completed which revealed a pneumothorax.A computed tomography scan was also performed showing the electrode in the left lobe of the lung.The system was explanted and a chest tube was placed.A transvenous system was subsequently implanted.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.A pneumothorax occurred during the implant procedure and evidence suggests the tunneling tool had entered the patient's lung.Please refer to the section b5 for more information regarding the specific circumstances of this event.
|
|
Event Description
|
It was reported that at implant of an subcutaneous implantable cardioverter defibrillator (s-icd), defibrillation threshold (dft) testing was initially unsuccessful at 65 joules.Additional external and device shocks were delivered which were unsuccessful.A commanded 80 joule shock was delivered which successfully converted the patient.At the time of the unsuccessful dft it was suspected to be due to low ef, however in the recovery room the patient reported feeling severe pain and nausea.A chest x-ray was completed which revealed a pneumothorax.A ct scan was also performed showing the electrode in the left lobe of the lung.The system was explanted and a chest tube was placed.A transvenous system was subsequently implanted.No additional adverse patient effects were reported.
|
|
Search Alerts/Recalls
|